Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Engineered Mitochondrial Vaccine in Advanced Solid Tumors
NCT06927297Phase 1Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- May 2025
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in solid tumor (advanced stage), sponsored by West China Hospital of Sichuan University. Primary endpoint: Adverse Events at 1 year. Started May 2025; status: recruiting.
02
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT06927297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06927297.